Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-11-07 | Future report Set alerts | |
Q2 2022 | 2022-08-09 | 0.86 | 0.86 |
Q1 2022 | 2022-05-10 | 1.10 | 1.10 |
Q4 2021 | 2022-03-01 | -0.04 | -0.04 |
Q3 2021 | 2021-11-08 | 1.20 | 1.20 |
Q2 2021 | 2021-08-09 | 0.71 | 0.71 |
Q1 2021 | 2021-05-10 | 0.87 | 0.87 |
Q4 2020 | 2021-03-01 | 0.45 | 0.45 |
Q3 2020 | 2020-11-09 | 0.00 | 0.00 |
Q2 2020 | 2020-08-10 | -0.10 | -0.10 |
2016-06-28 | Upgrade | Sidoti | Neutral to Buy | $34.00 |
2016-05-17 | Reiterated Rating | B. Riley | Neutral | $34.00 |
2016-05-16 | Boost Price Target | Citigroup Inc. | Buy | $33.00 to $35.00 |
2016-05-12 | Reiterated Rating | B. Riley | Neutral | $34.00 |
2016-04-24 | Downgrade | B. Riley | Neutral | $34.00 |
2016-04-19 | Downgrade | B. Riley | Buy to Neutral | $37.00 to $34.00 |
2016-03-22 | Downgrade | Sidoti | Buy to Neutral | $34.00 |
2016-03-20 | Reiterated Rating | B. Riley | Buy | $37.00 |
2016-03-15 | Boost Price Target | Citigroup Inc. | Buy | $32.00 to $33.00 |
2016-03-15 | Reiterated Rating | B. Riley | Buy | $37.00 |
2015-12-04 | Initiated Coverage | KeyBanc | Overweight | $33.00 |
2015-12-04 | Initiated Coverage | KeyCorp | Overweight | $33.00 |
2015-11-21 | Reiterated Rating | B. Riley | Buy | $38.00 |
2015-11-16 | Reiterated Rating | B. Riley | Buy | $38.00 |
2015-11-11 | Reiterated Rating | B. Riley | Buy | $38.00 |
2015-09-22 | Reiterated Rating | B. Riley | Buy | $38.00 |
2015-09-17 | Reiterated Rating | B. Riley | Buy | $38.00 |
2015-08-16 | Reiterated Rating | B. Riley | Buy | $38.00 |
2015-08-11 | Reiterated Rating | BWS Financial | Buy | $45.00 |
2015-08-10 | Reiterated Rating | B. Riley | Buy | $38.00 |
2015-08-01 | Reiterated Rating | B. Riley | Buy | $38.00 |
2015-07-26 | Reiterated Rating | B. Riley | Buy | $38.00 |
2015-07-24 | Reiterated Rating | Piper Jaffray | Neutral | $32.00 to $31.00 |
2015-07-24 | Reiterated Rating | Piper Jaffray Cos. | Neutral | $32.00 to $31.00 |
2015-05-13 | Reiterated Rating | B. Riley | Buy | $35.00 to $37.00 |
2015-05-12 | Reiterated Rating | Piper Jaffray | Neutral | $23.00 to $32.00 |
2015-05-04 | Initiated Coverage | BWS Financial | Buy | $45.00 |
2015-04-20 | Boost Price Target | Barclays | Buy | $32.00 to $37.00 |
2015-04-20 | Boost Price Target | Barclays PLC | Buy | $32.00 to $37.00 |
2015-03-13 | Reiterated Rating | B. Riley | Buy | $35.00 |
2014-12-16 | Reiterated Rating | B. Riley | Buy | $35.00 |
2014-12-11 | Initiated Coverage | Raymond James | Market Perform | |
2014-12-11 | Initiated Coverage | Raymond James Financial Inc. | Market Perform | |
2014-11-18 | Lower Price Target | Citigroup Inc. | Buy | $33.00 to $32.00 |
2014-11-18 | Upgrade | CIC Securities | Accumulate | |
2014-09-18 | Initiated Coverage | Piper Jaffray | Neutral | $36.00 |
2014-08-22 | Upgrade | Citigroup Inc. | Neutral to Buy | $29.00 to $33.00 |
2014-08-14 | Reiterated Rating | Citigroup Inc. | Neutral | $32.00 to $29.00 |
2014-07-25 | Reiterated Rating | Citigroup Inc. | Neutral | $36.00 to $32.00 |
2014-07-25 | Lower Price Target | B. Riley | Buy | $40.00 to $35.00 |
2014-07-24 | Lower Price Target | Oppenheimer | Outperform | $39.00 to $36.00 |
2014-07-24 | Lower Price Target | Oppenheimer Holdings Inc. | Outperform | $39.00 to $36.00 |
2014-06-16 | Upgrade | Sidoti | Neutral to Buy | |
2014-03-14 | Boost Price Target | B. Riley | $40.00 | |
2013-11-19 | Downgrade | Sidoti | Buy to Neutral | |
2013-11-08 | Boost Price Target | Oppenheimer | Outperform | $37.00 to $39.00 |
2013-10-25 | Boost Price Target | B. Riley | Buy | $34.00 to $39.00 |
2013-09-09 | Upgrade | B. Riley & Co. | Neutral to Buy | $33 to $34 |
2013-04-23 | Downgrade | B. Riley & Co. | Buy to Neutral | $27 to $31 |
2012-12-14 | Downgrade | Caris & Company | Above Average to Average | $20 to $22.50 |
2012-08-09 | Upgrade | Caris & Company | Average to Above Average | $18 to $20 |
2011-07-15 | Downgrade | Caris & Company | Buy to Average | |
2010-08-05 | Downgrade | Caris & Company | Buy to Above Average | |
2010-03-25 | Reiterated | Oppenheimer | Outperform | $15 to $18 |
2010-02-01 | Upgrade | HSBC Securities | Neutral to Overweight | |
2010-01-26 | Reiterated | Caris & Company | Buy | $16 to $18 |
2009-11-24 | Upgrade | Caris & Company | Above Average to Buy | $16.50 to $16 |
2009-10-23 | Reiterated | Caris & Company | Above Average | $14.50 to $16.50 |
2009-10-06 | Reiterated | Caris & Company | Above Average | $14 to $14.50 |
2009-09-16 | Reiterated | Caris & Company | Above Average | $12 to $14 |
2009-08-12 | Reiterated | Oppenheimer | Outperform | $10 to $11 |
2009-07-24 | Upgrade | Caris & Company | Average to Above Average | $8 to $9.50 |
2016-06-28 | Upgrade | Sidoti | Neutral to Buy | $34.00 |
2016-05-17 | Reiterated Rating | B. Riley | Neutral | $34.00 |
2016-05-16 | Boost Price Target | Citigroup Inc. | Buy | $33.00 to $35.00 |
2016-05-12 | Reiterated Rating | B. Riley | Neutral | $34.00 |
2016-04-24 | Downgrade | B. Riley | Neutral | $34.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In IPAR 169 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Inc. | 2.73M |
Vanguard Group, Inc | 2.07M |
BlackRock Fund Advisors | 1.37M |
DIMENSIONAL FUND ADVISORS LP | 0.89M |
ROYCE & ASSOCIATES LLC | 0.84M |
Copeland Capital Management, LLC | 0.64M |
STATE STREET CORP | 0.59M |
AMERIPRISE FINANCIAL INC | 0.59M |
NORTHERN TRUST CORP | 0.53M |
BlackRock Institutional Trust Company, N.A. | 0.44M |
PRICE T ROWE ASSOCIATES INC /MD/ | 0.41M |
WCM INVESTMENT MANAGEMENT/CA | 0.39M |
LORD, ABBETT & CO. LLC | 0.39M |
Cortina Asset Management, LLC | 0.37M |
FORT PITT CAPITAL GROUP INC | 0.36M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
MADAR JEAN CEO | 0.24% (74407) | IPAR / |
HEILBRONN FRANCOIS | 0.10% (31063) | IPAR / |
BENACIN PHILIPPE Pres Interparfums SA | 0.09% (27923) | IPAR / |
BENSOUSSAN TORRES ROBERT | 0.01% (3500) | IPAR / LULU / |
LEVY JEAN | 0.01% (2500) | IPAR / |
Clarke Henry B. President Inter Parfums USA | 0.01% (1625) | IPAR / |